FLUVOXAMINE Drug Patent Profile
✉ Email this page to a colleague
When do Fluvoxamine patents expire, and what generic alternatives are available?
Fluvoxamine is a drug marketed by Actavis Elizabeth, Ajanta Pharma Ltd, Annora Pharma, Appco, Bionpharma, Ph Health, Torrent, Aiping Pharm Inc, Ani Pharms, Apotex, Chartwell Rx, Heritage Pharma, Mylan, Quagen, Sun Pharm Industries, Synthon Pharms, Teva, and Upsher Smith Labs. and is included in twenty-one NDAs.
The generic ingredient in FLUVOXAMINE is fluvoxamine maleate. There are eleven drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the fluvoxamine maleate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Fluvoxamine
A generic version of FLUVOXAMINE was approved as fluvoxamine maleate by AIPING PHARM INC on November 29th, 2000.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for FLUVOXAMINE?
- What are the global sales for FLUVOXAMINE?
- What is Average Wholesale Price for FLUVOXAMINE?
Summary for FLUVOXAMINE
| US Patents: | 0 |
| Applicants: | 18 |
| NDAs: | 21 |
| Drug Prices: | Drug price information for FLUVOXAMINE |
| DailyMed Link: | FLUVOXAMINE at DailyMed |


